NATALIZUMAB and MALAISE

7,318 reports of this reaction

2.5% of all NATALIZUMAB reports

#9 most reported adverse reaction

Overview

MALAISE is the #9 most commonly reported adverse reaction for NATALIZUMAB, manufactured by Biogen Inc.. There are 7,318 FDA adverse event reports linking NATALIZUMAB to MALAISE. This represents approximately 2.5% of all 289,050 adverse event reports for this drug.

NATALIZUMAB has an overall safety score of 75 out of 100. Patients taking NATALIZUMAB who experience malaise should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

MALAISE7,318 of 289,050 reports

MALAISE is a less commonly reported adverse event for NATALIZUMAB, but still significant enough to appear in the safety profile.

Other Side Effects of NATALIZUMAB

In addition to malaise, the following adverse reactions have been reported for NATALIZUMAB:

FATIGUE — 19,460 reports
MULTIPLE SCLEROSIS RELAPSE — 16,794 reports
HEADACHE — 9,914 reports
MULTIPLE SCLEROSIS — 9,700 reports
GAIT DISTURBANCE — 9,473 reports
FALL — 8,004 reports
ASTHENIA — 7,983 reports
MEMORY IMPAIRMENT — 7,926 reports
DRUG INEFFECTIVE — 6,892 reports
URINARY TRACT INFECTION — 6,286 reports

Other Drugs Associated with MALAISE

The following drugs have also been linked to malaise in FDA adverse event reports:

0XYGEN ACETAMINOPHEN ACETAMINOPHEN 500MG ACETAMINOPHEN AND CODEINE PHOSPHATE ACETAMINOPHEN AND DIPHENHYDRAMINE HYDROCHLORIDE ACETAMINOPHEN AND IBUPROFEN ACETAMINOPHEN, ASPIRIN, AND CAFFEINE ACETAMINOPHEN, ASPIRIN (NSAID) AND CAFFEINE ACETAMINOPHEN, CAFFEINE ACETAMINOPHEN, CAFFEINE, PYRILAMINE MALEATE ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL ACETAMINOPHEN, DEXTROMETHORPHAN HBR, DOXYLAMINE SUCCINATE ACETAMINOPHEN, DEXTROMETHORPHAN HBR, PHENYLEPHRINE HCL ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, AND DOXYLAMINE SUCCINATE ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, AND PHENYLEPHRINE HYDROCHLORIDE ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, PHENYLEPHRINE HYDROCHLORIDE ACETAMINOPHEN, DIPHENHYDRAMINE HCL ACETAMINOPHEN, DIPHENHYDRAMINE HCL, PHENYLEPHRINE HCL ACETAMINOPHEN, DIPHENHYDRAMINE HYDROCHLORIDE

Frequently Asked Questions

Does NATALIZUMAB cause MALAISE?

MALAISE has been reported as an adverse event in 7,318 FDA reports for NATALIZUMAB. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is MALAISE with NATALIZUMAB?

MALAISE accounts for approximately 2.5% of all adverse event reports for NATALIZUMAB, making it a notable side effect.

What should I do if I experience MALAISE while taking NATALIZUMAB?

If you experience malaise while taking NATALIZUMAB, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

NATALIZUMAB Full Profile All Drugs Causing MALAISE Biogen Inc. Drugs

Disclaimer: This analysis is based on FDA adverse event reports and is for informational purposes only. Reports do not prove causation. Always consult your healthcare provider.